Advertising Disclaimer
Published online January 15, 2007
PEDIATRICS Vol. 119 No. 2 February 2007, pp. e419-e425 (doi:10.1542/peds.2006-1862)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vlahos, A. P.
Right arrow Articles by Kolettis, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vlahos, A. P.
Right arrow Articles by Kolettis, T. M.
Related Collections
Right arrow Heart & Blood Vessels
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Provocation of Neurocardiogenic Syncope During Head-up Tilt Testing in Children: Comparison Between Isoproterenol and Nitroglycerin

Antonios P. Vlahos, MDa, Meropi Tzoufi, MDa, Christos S. Katsouras, MDb, Theodora Barka, RNb, Irene Sionti, MDc, Lampros K. Michalis, MDb, Antigoni Siamopoulou, MDa, Theofilos M. Kolettis, MDb

a Departments of Child Health
b Cardiology, University of Ioannina, Ioannina, Greece
c Department of Pediatrics, University Hospital of Ioannina, Ioannina, Greece

OBJECTIVE. Although nitroglycerin- and isoproterenol-augmented tilt tests are of equal value in the diagnosis of neurocardiogenic syncope in adults, no data exist in children. We compared the sensitivity and specificity of the 2 tests in a pediatric population.

PATITENS AND METHODS. We studied 85 patients (33 boys; mean age: 11.6 ± 2.9 years). Of them, 56 had a diagnostic history of neurocardiogenic syncope, whereas 29 served as controls. After a negative passive phase, they were randomly assigned to either intravenous isoproterenol or sublingual nitroglycerin, and tilt was continued for 20 minutes.

RESULTS. Sensitivity was 0.78 for the isoproterenol test and 0.79 for the nitroglycerin test, but specificity was significantly higher for isoproterenol test compared with nitroglycerin test. In patients with a positive test, the duration of the recovery period was significantly longer after nitroglycerin (8.4 ± 2.7 minutes) than after isoproterenol (5.1 ± 1.6 minutes).

CONCLUSIONS. Nitroglycerin- and isoproterenol-augmented tilt tests are associated with equal sensitivity in the diagnosis of neurocardiogenic syncope in children and adolescents. However, nitroglycerin results in more false-positive tests and produces more prolonged vasovagal symptoms. Our data do not support the routine use of nitroglycerin in the evaluation of syncope in this age group.


Key Words: neurocardiogenic syncope • tilt test • children • isoproterenol • nitroglycerin

Abbreviations: CI—confidence interval


Accepted Aug 30, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Eur Heart JHome page
Developed in collaboration with, European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), and Heart Rhythm Society (HRS), Endorsed by the following societies, European Society of Emergency Medicine (EuSEM), European Federation of Internal Medicine (EFIM), European Union Geriatric Medicine Society (EUGMS), American Geriatrics Society (AGS), European Neurological Society (ENS), et al.
Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)
Eur. Heart J., November 1, 2009; 30(21): 2631 - 2671.
[Full Text] [PDF]


Home page
Eur Heart JHome page
G. Foglia-Manzillo and F. Giada
Tilt testing potentiated with sublingual nitroglycerin in children with unexplained syncope: reply
Eur. Heart J., April 2, 2008; 29(8): 1075 - 1075.
[Full Text] [PDF]


Home page
Eur Heart JHome page
E. Jastrzebska-Maj, K. Mizia-Stec, and D. Jakubowski
Tilt testing potentiated with sublingual nitroglycerin in children with unexplained syncope
Eur. Heart J., April 2, 2008; 29(8): 1074 - 1075.
[Full Text] [PDF]